102 related articles for article (PubMed ID: 23486493)
1. Chlamydia screening coverage estimates derived using healthcare effectiveness data and information system procedures and indirect estimation vary substantially.
Broad JM; Manhart LE; Kerani RP; Scholes D; Hughes JP; Golden MR
Sex Transm Dis; 2013 Apr; 40(4):292-7. PubMed ID: 23486493
[TBL] [Abstract][Full Text] [Related]
2. Estimating chlamydia screening coverage: a comparison of self-report and health care effectiveness data and information set measures.
Khosropour CM; Broad JM; Scholes D; Saint-Johnson J; Manhart LE; Golden MR
Sex Transm Dis; 2014 Nov; 41(11):665-70. PubMed ID: 25299413
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia testing patterns for commercially insured women, 2008.
Tao G; Hoover KW; Kent CK
Am J Prev Med; 2012 Apr; 42(4):337-41. PubMed ID: 22424245
[TBL] [Abstract][Full Text] [Related]
4. Understanding sexual activity defined in the HEDIS measure of screening young women for Chlamydia trachomatis.
Tao G; Walsh CM; Anderson LA; Irwin KL
Jt Comm J Qual Improv; 2002 Aug; 28(8):435-40. PubMed ID: 12182161
[TBL] [Abstract][Full Text] [Related]
5. Indirect estimation of Chlamydia screening coverage using public health surveillance data.
Levine WC; Dicker LW; Devine O; Mosure DJ
Am J Epidemiol; 2004 Jul; 160(1):91-6. PubMed ID: 15229122
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):362-5. PubMed ID: 19373196
[TBL] [Abstract][Full Text] [Related]
7. Direct and indirect effects of screening for Chlamydia trachomatis on the prevention of pelvic inflammatory disease: a mathematical modeling study.
Herzog SA; Heijne JC; Scott P; Althaus CL; Low N
Epidemiology; 2013 Nov; 24(6):854-62. PubMed ID: 24076992
[TBL] [Abstract][Full Text] [Related]
8. Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002.
Lofy KH; Hofmann J; Mosure DJ; Fine DN; Marrazzo JM
Sex Transm Dis; 2006 Feb; 33(2):63-7. PubMed ID: 16432475
[TBL] [Abstract][Full Text] [Related]
9. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia screening among sexually active young female enrollees of health plans--United States, 1999-2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(42):983-5. PubMed ID: 15514579
[TBL] [Abstract][Full Text] [Related]
11. Validation of data collection for the HEDIS performance measure on chlamydia screening in an MCO.
Wei F; Walsh CM
Am J Manag Care; 2003 Sep; 9(9):585-93. PubMed ID: 14527104
[TBL] [Abstract][Full Text] [Related]
12. Modelling the impact of opportunistic screening on the sequelae and public healthcare costs of infection with Chlamydia trachomatis in Australian women.
Ward B; Rodger AJ; Jackson TJ
Public Health; 2006 Jan; 120(1):42-9. PubMed ID: 16271271
[TBL] [Abstract][Full Text] [Related]
13. Effects of screening and partner notification on Chlamydia positivity in the United States: a modeling study.
Kretzschmar M; Satterwhite C; Leichliter J; Berman S
Sex Transm Dis; 2012 May; 39(5):325-31. PubMed ID: 22504590
[TBL] [Abstract][Full Text] [Related]
14. Estimating Chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States.
Tao G; Tian LH; Peterman TA
Sex Transm Dis; 2007 Mar; 34(3):180-2. PubMed ID: 16865052
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia trachomatis infections among women attending prenatal clinics: United States, 2004-2009.
Satterwhite CL; Gray AM; Berman S; Weinstock H; Kleinbaum D; Howards PP
Sex Transm Dis; 2012 Jun; 39(6):416-20. PubMed ID: 22592825
[TBL] [Abstract][Full Text] [Related]
16. The contribution of a urine-based jail screening program to citywide male Chlamydia and gonorrhea case rates in New York City.
Pathela P; Hennessy RR; Blank S; Parvez F; Franklin W; Schillinger JA
Sex Transm Dis; 2009 Feb; 36(2 Suppl):S58-61. PubMed ID: 17989586
[TBL] [Abstract][Full Text] [Related]
17. The English National Chlamydia Screening Programme: variations in positivity in 2007/2008.
Simms I; Talebi A; Rhia J; Horner P; French RS; Sarah R; Macintosh M
Sex Transm Dis; 2009 Aug; 36(8):522-7. PubMed ID: 19455079
[TBL] [Abstract][Full Text] [Related]
18. Estimating chlamydia re-infection rates: an empirical example.
Torrone EA; Satterwhite CL; Scholes D; Yu O; Berman S; Peterman TA
Sex Transm Infect; 2013 Aug; 89(5):388-90. PubMed ID: 23644175
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of strategies to increase chlamydia screening in young women.
Scholes D; Grothaus L; McClure J; Reid R; Fishman P; Sisk C; Lindenbaum JE; Green B; Grafton J; Thompson RS
Prev Med; 2006 Oct; 43(4):343-50. PubMed ID: 16782182
[TBL] [Abstract][Full Text] [Related]
20. Association of insurance coverage with chlamydia screening.
Pourat N; Tao GA; Walsh CM
Am J Manag Care; 2008 Apr; 14(4):197-204. PubMed ID: 18402512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
